SUSQUEHANNA INTERNATIONAL GROUP, LLP - FULCRUM THERAPEUTICS INC ownership

FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 83 filers reported holding FULCRUM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of FULCRUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,338,950
+125.1%
977,241
+67.3%
0.00%
Q2 2023$1,927,623
+81.0%
584,128
+56.3%
0.00%
Q1 2023$1,065,236
-44.3%
373,767
+42.4%
0.00%
Q4 2022$1,911,000
-22.0%
262,500
-13.3%
0.00%
-100.0%
Q3 2022$2,450,000
+97.6%
302,806
+19.7%
0.00%
Q2 2022$1,240,000
-47.8%
252,987
+152.0%
0.00%
Q1 2022$2,374,000
+6.8%
100,400
-20.1%
0.00%
Q4 2021$2,222,000
+0.5%
125,600
+60.2%
0.00%
Q3 2021$2,211,000
+494.4%
78,400
+148.1%
0.00%
Q1 2021$372,000
+318.0%
31,594
+135.8%
0.00%
Q3 2019$89,00013,3970.00%
Other shareholders
FULCRUM THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TRV GP IV, LLC 2,343,154$10,403,6043.92%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,718,881$25,391,8321.37%
COWEN AND COMPANY, LLC 4,308,359$19,129,1131.34%
RA Capital Management 11,609,704$51,547,0861.02%
RTW INVESTMENTS, LP 5,818,804$25,835,4900.54%
Acuitas Investments, LLC 134,811$598,5610.35%
Simplify Asset Management Inc. 570,519$2,533,1040.29%
Vivo Capital, LLC 520,000$2,308,8000.25%
BRANDYWINE MANAGERS, LLC 26,127$116,0040.20%
DENALI ADVISORS LLC 70,600$313,4640.11%
View complete list of FULCRUM THERAPEUTICS INC shareholders